CDMRP Features PCCTC-Managed PROMISE Registry

Sep 24

Written By Kristofer Prepelica, PhD

Kristofer Prepelica, PhD

Summer Internships Announced

ESMO 2024: CC-94676-PCA-001: Clinical Activity of BMS-986365, a Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, in Heavily Pretreated Patients with mCRPC